Patents by Inventor Beverley Greenwood

Beverley Greenwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spinal cord stimulation as treatment for functional bowel disorders
    Patent number: 7251529
    Abstract: The present invention relates to treatment of visceral pain of gastrointestinal origin, functional bowel disorders and irritable bowel syndrome comprising electrical stimulation of the spinal cord using one or more commercially available and implantable spinal cord stimulation leads for a time period sufficient to suppress or extinguish the pain or symptoms associated with visceral pain of gastrointestinal origin, functional bowel disorders or irritable bowel syndrome.
    Type: Grant
    Filed: May 29, 2003
    Date of Patent: July 31, 2007
    Assignee: Oklahoma Foundation for Digestive Research
    Inventor: Beverley Greenwood-Van Meerveld
  • Spinal cord stimulation as treatment for functional bowel disorders
    Publication number: 20040039425
    Abstract: The present invention relates to treatment of visceral pain of gastrointestinal origin, functional bowel disorders and irritable bowel syndrome comprising electrical stimulation of the spinal cord using one or more commercially available and implantable spinal cord stimulation leads for a time period sufficient to suppress or extinguish the pain or symptoms associated with visceral pain of gastrointestinal origin, functional bowel disorders or irritable bowel syndrome.
    Type: Application
    Filed: May 29, 2003
    Publication date: February 26, 2004
    Inventor: Beverley Greenwood-Van Meerveld
  • Method of treating gastrointestinal motility disorders
    Patent number: 6281232
    Abstract: The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 28, 2001
    Assignee: Novo Nordisk A/S
    Inventor: Beverley Greenwood
  • Method of treating gastrointestinal motility disorders
    Patent number: 6281233
    Abstract: The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 28, 2001
    Assignee: Novo Nordisk A/S
    Inventor: Beverley Greenwood
  • Method of treating gastrointestinal motility disorders
    Patent number: 6271229
    Abstract: The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 7, 2001
    Assignee: Novo Nordisk A/S
    Inventor: Beverley Greenwood
  • Method of treating gastrointestinal motility disorders
    Patent number: 6265419
    Abstract: The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.
    Type: Grant
    Filed: December 7, 1994
    Date of Patent: July 24, 2001
    Assignee: Novo Nordisk A/S
    Inventor: Beverley Greenwood
  • Method of treating gastrointestinal motility disorders
    Patent number: 5744489
    Abstract: The present invention relates to a method for treating a mammal suffering from gastrointestinal motility disorders comprising administering certain thiadiazole and oxadiazole compounds that are herein disclosed.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: April 28, 1998
    Inventor: Beverley Greenwood
  • Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
    Patent number: 5643926
    Abstract: Novel substituted pyrazolidinones have been found to exhibit significant binding to cholecystokinin (CCK) receptors and gastrin receptors in the brain and/or peripheral sites such as the pancreas, stomach, and ileum. The pyrazolidinones are CCK and gastrin receptor antagonists and find therapeutic application in the treatment of gastrointestinal disorders, central nervous system disorders and for appetite regulation in warm-blood vertebrates. Pharmaceutical formulations for such indications are described.
    Type: Grant
    Filed: January 19, 1994
    Date of Patent: July 1, 1997
    Assignee: Eli Lilly and Company
    Inventors: Raymond F. Brown, J. Jeffry Howbert, Karen L. Lobb, David A. Neel, Jon K. Reel, Beverley Greenwood
  • Method of treating gastrointestinal motility disorders
    Patent number: 5545638
    Abstract: The present invention relates to a novel method for treating a mammal suffering from gastrointestinal motility disorders.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 13, 1996
    Assignee: Novo Nordisk A/S
    Inventor: Beverley Greenwood
  • Thieno[1,5]benzoidiazepine use
    Patent number: 5457101
    Abstract: The compound 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of certain gastrointestinal disorders.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: October 10, 1995
    Assignee: Eli Lilly and Company
    Inventors: Beverley Greenwood, David L. G. Nelson
  • Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
    Patent number: 5399565
    Abstract: Novel substituted pyrazolidinones have been found to exhibit significant binding to cholecystokinin (CCK) receptors and gastrin receptors in the brain and/or peripheral sites such as the pancreas, stomach, and ileum. The pyrazolidinones are CCK and gastrin receptor antagonists and find therapeutic application in the treatment of gastrointestinal disorders, central nervous system disorders and for appetite regulation in warm-blood vertebrates. Pharmaceutical formulations for such indications are described.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: March 21, 1995
    Assignee: Eli Lilly and Company
    Inventors: Beverley Greenwood, David R. Helton, J. Jeffry Howbert, Steven J. Mitan, Kurt Rasmussen
  • Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
    Patent number: 5300514
    Abstract: Novel substituted pyrazolidinones have been found to exhibit significant binding to cholecystokinin (CCK) receptors and gastrin receptors in the brain and/or peripheral sites such as the pancreas, stomach, and ileum. The pyrazolidinones are CCK and gastrin receptor antagonists and find therapeutic application in the treatment of gastrointestinal disorders, central nervous system disorders and for appetite regulation in warm-blood vertebrates. Pharmaceutical formulations for such indications are described.
    Type: Grant
    Filed: March 18, 1993
    Date of Patent: April 5, 1994
    Assignee: Eli Lilly and Company
    Inventors: Raymond F. Brown, J. Jeffry Howbert, Karen L. Lobb, David A. Neel, Jon K. Reel, Beverley Greenwood